Schulze-Osthoff K, Bakker A C, Vanhaesebroeck B, Beyaert R, Jacob W A, Fiers W
Laboratory of Molecular Biology, State University, Gent, Belgium.
J Biol Chem. 1992 Mar 15;267(8):5317-23.
Structural mitochondrial damage accompanies the cytotoxic effects of several drugs including tumor necrosis factor (TNF). Using various inhibitors of mitochondrial electron transport we have investigated the mechanism of TNF-mediated cytotoxicity in L929 and WEHI 164 clone 13 mouse fibrosarcoma cells. Inhibitors with different sites of action modulated TNF cytotoxicity, however, with contrasting effects on final cell viability. Inhibition of mitochondrial electron transport at complex III (cytochrome c reductase) by antimycin A resulted in a marked potentiation of TNF-mediated injury. In contrast, when the electron flow to ubiquinone was blocked, either at complex I (NADH-ubiquinone oxidoreductase) with amytal or at complex II (succinate-ubiquinone reductase) with thenoyltrifluoroacetone, cells were markedly protected against TNF cytotoxicity. Neither uncouplers nor inhibitors of oxidative phosphorylation nor complex IV (cytochrome c oxidase) inhibitors significantly interfered with TNF-mediated effects, ruling out the involvement of energy-coupled phenomena. In addition, the toxic effects of TNF were counteracted by the addition of antioxidants and iron chelators. Furthermore, we analyzed the direct effect of TNF on mitochondrial morphology and functions. Treatment of L929 cells with TNF led to an early degeneration of the mitochondrial ultrastructure without any pronounced damage of other cellular organelles. Analysis of the mitochondrial electron flow revealed that TNF treatment led to a rapid inhibition of the mitochondria to oxidize succinate and NADH-linked substrates. The inhibition of electron transport was dose-dependent and became readily detectable 60 min after the start of TNF treatment, thus preceding the onset of cell death by at least 3-6 h. In contrast, only minor effects were observed on complex IV activity. The different effects observed with the mitochondrial respiratory chain inhibitors provide suggestive evidence that mitochondrial production of oxygen radicals mainly generated at the ubisemiquinone site is a causal mechanism of TNF cytotoxicity. This conclusion is further supported by the protective effect of antioxidants as well as the selective pattern of damage of mitochondrial chain components and characteristic alterations of the mitochondrial ultrastructure.
线粒体结构损伤伴随着包括肿瘤坏死因子(TNF)在内的几种药物的细胞毒性作用。我们使用线粒体电子传递的各种抑制剂,研究了TNF在L929和WEHI 164克隆13小鼠纤维肉瘤细胞中介导的细胞毒性机制。作用于不同位点的抑制剂调节了TNF的细胞毒性,然而,对最终细胞活力有相反的影响。抗霉素A对复合体III(细胞色素c还原酶)处的线粒体电子传递的抑制导致TNF介导的损伤明显增强。相反,当电子流向泛醌的过程被阻断时,无论是在复合体I(NADH - 泛醌氧化还原酶)处用阿米妥,还是在复合体II(琥珀酸 - 泛醌还原酶)处用噻吩甲酰三氟丙酮,细胞都能得到显著保护,免受TNF的细胞毒性作用。解偶联剂、氧化磷酸化抑制剂或复合体IV(细胞色素c氧化酶)抑制剂均未显著干扰TNF介导的效应,排除了能量偶联现象的参与。此外,添加抗氧化剂和铁螯合剂可抵消TNF的毒性作用。此外,我们分析了TNF对线粒体形态和功能的直接影响。用TNF处理L929细胞导致线粒体超微结构早期退化,而其他细胞器没有任何明显损伤。对线粒体电子流的分析表明,TNF处理导致线粒体氧化琥珀酸和NADH连接底物的能力迅速受到抑制。电子传递的抑制是剂量依赖性的,在TNF处理开始后60分钟即可轻易检测到,因此至少在细胞死亡开始前3 - 6小时出现。相反,对复合体IV活性仅观察到轻微影响。线粒体呼吸链抑制剂观察到的不同效应提供了提示性证据,表明主要在半醌位点产生的线粒体氧自由基生成是TNF细胞毒性的因果机制。抗氧化剂的保护作用以及线粒体链成分损伤的选择性模式和线粒体超微结构的特征性改变进一步支持了这一结论。